Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grace-2: GS1-144 for moderate to severe vasomotor symptoms in postmenopausal Chinese women
ChiCTR2500098244Phase 2Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GS1-144 in vasomotor symptoms (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: VMS electronic diary evaluation. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
GS1-144
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on ChiCTR2500098244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098244.